Hanwha wins S.Korean military anti-drone system deals

Hanwha wins S.Korean military anti-drone system deals

South Korean aerospace and defense maker Hanwha Systems Co. is set to establish a military system to cope with small unmanned aerial vehicles (UAVs)...

Boryung, HK inno.N to co-market Kanarb, K-CAB

Boryung, HK inno.N to co-market Kanarb, K-CAB

South Korea’s pharmaceutical companies Boryung Corp. and HK inno.N announced on Wednesday that they will start co-marketing for their respec...

Icure wins $2.85 mn lidocaine cataplasm order from Guatemala

Icure wins $2.85 mn lidocaine cataplasm order from Guatemala

South Korea's Icure Pharmaceutical Incorporation announced on Tuesday that it signed a supply contract for the specialized local anesthetic lidoca...

Lunit acquires NZ-based AI diagnostics firm Volpara

Lunit acquires NZ-based AI diagnostics firm Volpara

South Korean medical AI company Lunit announced on Thursday that it will acquire New Zealand-based AI breast cancer diagnostics solutions company Vo...

HK inno.N reveals differentiated clinical results for K-CAB

HK inno.N reveals differentiated clinical results for K-CAB

South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...

S.Korea’s GC Cell targets global cell therapy CDMO business

S.Korea’s GC Cell targets global cell therapy CDMO business

GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...

Celltrion’s Vegzelma listed on US PBM preferred drug list

Celltrion’s Vegzelma listed on US PBM preferred drug list

South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...

ISU Abxis gets patent for Alzheimer drug candidate in Taiwan

ISU Abxis gets patent for Alzheimer drug candidate in Taiwan

South Korea's ISU Abxis Co. announced on Friday that its Alzheimer's treatment candidate ISU203 has received a substance patent registration decisio...

Celltrion Healthcare's Herzuma selected as funded brand in NZ

Celltrion Healthcare's Herzuma selected as funded brand in NZ

Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...

Celltrion, Cyron to develop multi-specific antibody new drug

Celltrion, Cyron to develop multi-specific antibody new drug

South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...

Daewoong Pharm set to export Envlo Tab to Russia, CIS

Daewoong Pharm set to export Envlo Tab to Russia, CIS

Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...

Korea to invest $200 mn in new drugs, vaccines by 2028

Korea to invest $200 mn in new drugs, vaccines by 2028

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

HD Hyundai builds Aegis destroyer with anti-ballistic missiles

HD Hyundai builds Aegis destroyer with anti-ballistic missiles

ULSAN, South Korea –  At the shipyard of HD Hyundai Heavy Industries Co. on Nov. 20 in Ulsan, South Gyeongsang Province, South Korea's ne...

Cytogen, Japan NCCH collaborate on cancer research

Cytogen, Japan NCCH collaborate on cancer research

South Korea's Cytogen, Inc. announced on Monday it will start cancer research using circulating tumor cells (CTC) with the National Cancer Center Ho...

SK Biopharm gears up to boost epilepsy drug sales in Europe

SK Biopharm gears up to boost epilepsy drug sales in Europe

SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...

South Korean bio, pharma industry set to take leap

South Korean bio, pharma industry set to take leap

South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...

Lunit gets FDA approval for AI cancer diagnosis solution

Lunit gets FDA approval for AI cancer diagnosis solution

South Korean medical AI company Lunit said on Tuesday its Lunit Insight DBT, an AI imaging diagnosis solution aiding in breast cancer diagnosis, has...

'World-class bispecific antibody technology of ABL Bio'

'World-class bispecific antibody technology of ABL Bio'

MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...

Lunit participates in US gov't Cancer Moonshot

Lunit participates in US gov't Cancer Moonshot

South Korea's medical AI company Lunit announced on Friday it will participate in the US President Joe Biden's cancer-conquering project Cancer Moon...

Gencurix gets FDA OK for breast cancer prognosis analysis device

Gencurix gets FDA OK for breast cancer prognosis analysis device

South Korean biotech company Gencurix Inc. announced on Wednesday its subsidiary GenoBio has received approval from the US Food and Drug Admini...

SK Telecom invests in AI startups Allganize, Imprimed

SK Telecom invests in AI startups Allganize, Imprimed

SK Telecom Co. has invested a combined 9.4 billion won ($7.2 million) in artificial intelligence startups Allganize Inc. and Imprimed Inc., the top ...

Daewoong Pharma, Merck team up for AI tech for new drug

Daewoong Pharma, Merck team up for AI tech for new drug

South Korea's Daewoong Pharmaceutical announced on Tuesday it signed with memorandum of understanding (MOU) with Merck Life Science to build an arti...

Lotte builds US antibody-drug conjugate plant with $82 mn

Lotte builds US antibody-drug conjugate plant with $82 mn

South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...

Samsung Biologics eyes new drugmaker acquisitions

Samsung Biologics eyes new drugmaker acquisitions

BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugma...

Theraject Asia applies for microneedle patent in US

Theraject Asia applies for microneedle patent in US

South Korean microneedle company Theraject Asia on Thursday said it recently applied for a US patent for a medical microneedle, specifically a const...

Medytox to enter China’s botulinum toxin market with Newlux

Medytox to enter China’s botulinum toxin market with Newlux

South Korean pharmaceutical company Medytox Inc. on Tuesday announced its plan to enter the Chinese market for botulinum toxins (BTX) with its cut...

VaxCell-Bio applies for approval of anti-cancer drug for dogs

VaxCell-Bio applies for approval of anti-cancer drug for dogs

South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...

Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved

Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved

South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...

Korea’s antitrust body grants conditional OK to Broadcom-VMware deal

Korea’s antitrust body grants conditional OK to Broadcom-VMware deal

South Korea’s antitrust regulator on Monday granted conditional approval for US smartphone components maker Broadcom Inc.’s proposed pur...

Celltrion gets FDA approval for Remsima SC

Celltrion gets FDA approval for Remsima SC

South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...

HYBE Chair Bang referred to prosecutors over alleged unfair trading Vietnam’s top leader to make 1st South Korea visit in 11 years Test case looms for Korea’s revised Commercial Act as VIP Asset challenges Lotte Rental’s rights issue to Affinity HYBE sparks summer vibes with BTS live album, TXT comeback, new boy band launch K-beauty contract manufacturers see record Q2 profits; rally likely to continue